Jazz Pharmaceuticals (JAZZ) EBT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 372.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 372.50% |
| Dec 31, 2025 | 56.49% |
| Sep 30, 2025 | -95.50% |
| Jun 30, 2025 | -633.29% |
| Mar 31, 2025 | -6,753.93% |
| Dec 31, 2024 | 116.52% |
| Sep 30, 2024 | 101.78% |
| Jun 30, 2024 | 68.65% |
| Mar 31, 2024 | -102.91% |
| Dec 31, 2023 | 118.10% |
| Sep 30, 2023 | 265.50% |
| Jun 30, 2023 | 289.19% |
| Mar 31, 2023 | 771.16% |
| Dec 31, 2022 | -658.41% |
| Sep 30, 2022 | 11.10% |
| Jun 30, 2022 | 115.44% |
| Mar 31, 2022 | -95.34% |
| Dec 31, 2021 | -130.96% |
| Sep 30, 2021 | -140.22% |
| Jun 30, 2021 | -179.36% |
| Mar 31, 2021 | 164.83% |
| Dec 31, 2020 | 255.20% |
| Sep 30, 2020 | 47.22% |
| Jun 30, 2020 | -6.88% |
| Mar 31, 2020 | -281.67% |
| Dec 31, 2019 | -75.36% |
| Sep 30, 2019 | -32.46% |
| Jun 30, 2019 | 42.25% |
| Mar 31, 2019 | 75.96% |
| Dec 31, 2018 | 39.13% |
| Sep 30, 2018 | 160.00% |
| Jun 30, 2018 | -8.41% |
| Mar 31, 2018 | -43.48% |
| Dec 31, 2017 | -21.40% |
| Sep 30, 2017 | -44.11% |
| Jun 30, 2017 | -9.76% |
| Mar 31, 2017 | 7.10% |
| Dec 31, 2016 | 56.79% |
| Sep 30, 2016 | -1.30% |
| Jun 30, 2016 | 31.87% |
| Mar 31, 2016 | 5.25% |
| Dec 31, 2015 | -16.26% |
| Sep 30, 2015 | 135.86% |
| Jun 30, 2015 | 88.70% |
| Mar 31, 2015 | 234.13% |
| Sep 30, 2014 | -46.67% |
| Jun 30, 2014 | -4.34% |
| Mar 31, 2014 | -225.47% |
| Sep 30, 2013 | 101.81% |
| Jun 30, 2013 | 74.48% |
| Mar 31, 2013 | 70.78% |
| Dec 31, 2012 | 53.30% |
| Sep 30, 2012 | 43.01% |
| Jun 30, 2012 | 13.57% |
| Mar 31, 2012 | 63.80% |
| Dec 31, 2011 | 180.11% |
| Sep 30, 2011 | 145.28% |
| Jun 30, 2011 | 221.38% |